Invention Grant
- Patent Title: Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
-
Application No.: US14216222Application Date: 2014-03-17
-
Publication No.: US09656955B2Publication Date: 2017-05-23
- Inventor: Wilhelm Amberg , Frauke Pohlki , Udo Lange , Ying X. Wang , Hongyu H. Zhao , Huan-Qiu Li , Jason T. Brewer , Irini Zanze , Justin Dietrich , Anil Vasudevan , Stevan W. Djuric , Yanbin Lao , Charles W. Hutchins
- Applicant: AbbVie Deutschland GmbH & Co. KG , AbbVie Inc.
- Applicant Address: US IL North Chicago DE Wiesbaden
- Assignee: AbbVie Inc.,AbbVie Deutschland GmbH & Co. KG
- Current Assignee: AbbVie Inc.,AbbVie Deutschland GmbH & Co. KG
- Current Assignee Address: US IL North Chicago DE Wiesbaden
- Agency: Neal, Gerber & Eisenberg LLP
- Main IPC: A61K31/4025
- IPC: A61K31/4025 ; A61K31/44 ; A61K31/4178 ; C07D207/09 ; C07D403/12 ; C07D401/12 ; C07D207/48 ; C07D401/14 ; C07D403/14 ; C07D405/14 ; C07D487/10 ; C07D417/14 ; C07D409/14 ; C07D495/04 ; C07D471/04 ; C07D487/04
Abstract:
The present invention relates to pyrrolidine derivatives of the formula (I), or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such pyrrolidine derivatives, and the use of such pyrrolidine derivatives for therapeutic purposes. The pyrrolidine derivatives are GlyT1 inhibitors.
Public/Granted literature
- US20140275087A1 PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY Public/Granted day:2014-09-18
Information query
IPC分类:
